Type i and ii interferons in the anti-tumor immune response

97Citations
Citations of this article
122Readers
Mendeley users who have this article in their library.

Abstract

The interferons (IFNs) are essential components of the immune response against infec-tions and malignancies. IFNs are potent promoters of the anti-tumor response, but there is also evidence that feedback mechanisms regulated by IFNs negatively control immune responses to avoid hyper-activation and limit inflammation. This balance of responses plays an important role in cancer surveillance, immunoediting and response to anticancer therapeutic approaches. Here we review the roles of both type I and type II IFNs on the control of the immune response against malignancies in the context of effects on both malignant cells and cells of the immune system in the tumor microenvironment.

Cite

CITATION STYLE

APA

Fenton, S. E., Saleiro, D., & Platanias, L. C. (2021, March 1). Type i and ii interferons in the anti-tumor immune response. Cancers. MDPI AG. https://doi.org/10.3390/cancers13051037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free